SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-133228
Filing Date
2024-05-07
Accepted
2024-05-07 16:43:58
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d813401d10q.htm   iXBRL 10-Q 953629
2 EX-3.1 d813401dex31.htm EX-3.1 78166
3 EX-31.1 d813401dex311.htm EX-31.1 11250
4 EX-31.2 d813401dex312.htm EX-31.2 11258
5 EX-32.1 d813401dex321.htm EX-32.1 4530
  Complete submission text file 0001193125-24-133228.txt   5083761

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dbvt-20240331.xsd EX-101.SCH 45155
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbvt-20240331_cal.xml EX-101.CAL 42628
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbvt-20240331_def.xml EX-101.DEF 190321
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbvt-20240331_lab.xml EX-101.LAB 295230
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbvt-20240331_pre.xml EX-101.PRE 258667
79 EXTRACTED XBRL INSTANCE DOCUMENT d813401d10q_htm.xml XML 807141
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36697 | Film No.: 24922761
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)